RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 87 filers reported holding RELMADA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $38,073 | -55.1% | 15,477 | -58.7% | 0.00% | -100.0% |
| Q1 2023 | $84,752 | -40.3% | 37,501 | -7.8% | 0.00% | 0.0% |
| Q4 2022 | $142,008 | -89.1% | 40,690 | +15.8% | 0.00% | -85.7% |
| Q3 2022 | $1,300,000 | +65.6% | 35,125 | -15.0% | 0.01% | +40.0% |
| Q2 2022 | $785,000 | -13.7% | 41,317 | +22.5% | 0.01% | -37.5% |
| Q1 2022 | $910,000 | +4450.0% | 33,731 | +3610.8% | 0.01% | – |
| Q4 2021 | $20,000 | -94.6% | 909 | -93.5% | 0.00% | -100.0% |
| Q3 2021 | $369,000 | +846.2% | 14,060 | +1053.4% | 0.01% | – |
| Q2 2021 | $39,000 | +3800.0% | 1,219 | +4103.4% | 0.00% | – |
| Q1 2021 | $1,000 | -95.0% | 29 | -95.4% | 0.00% | – |
| Q4 2020 | $20,000 | -42.9% | 624 | -33.5% | 0.00% | -100.0% |
| Q3 2020 | $35,000 | – | 938 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 668,440 | $25,147,000 | 4.92% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $18,810,000 | 3.40% |
| ACUTA CAPITAL PARTNERS, LLC | 277,000 | $10,421,000 | 2.83% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 455,137 | $17,122,000 | 1.67% |
| RTW INVESTMENTS, LP | 1,511,337 | $56,857,000 | 1.37% |
| Avoro Capital Advisors LLC | 1,500,000 | $56,430,000 | 0.80% |
| Pegasus Asset Management, Inc. | 26,958 | $1,014,000 | 0.64% |
| RA Capital Management | 781,290 | $29,392,000 | 0.54% |
| TIEDEMANN ADVISORS, LLC | 269,839 | $10,151,000 | 0.49% |
| Boxer Capital, LLC | 300,000 | $11,286,000 | 0.39% |